Trastuzumab Optimization Trial in Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic or Locally Advanced Breast Cancer
Interventions: DRUG: trastuzumab
Sponsor: Regione Lombardia
Collaborators: Mario Negri Institute for Pharmacological Research|Istituto Clinico Humanitas